Form 4: Guardant Health's Co-CEO Helmy Eltoukhy Exercises Stock Options
SEC Form 4 Filing
Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., exercised stock options to acquire 200,000 shares of common stock at a price of $4.18 per share on May 3, 2024.
Summary
- On May 3, 2024, Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., exercised stock options.
- This transaction involved the acquisition of 200,000 shares of common stock at a price of $4.18 per share.
- Following the transaction, Eltoukhy directly owns 2,292,961 shares of Guardant Health common stock.
- He also directly owns 511,612 derivative securities (stock options).
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing an executive's stock option exercise. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.
Stakeholder Impact
- The transaction may have a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| 04/23/2017 | Commencement date for the vesting of the stock option in equal monthly installments over 48 months. |
| 07/14/2027 | Expiration date of the stock options. |
| 05/03/2024 | Date of the transaction where stock options were exercised. |
| 05/06/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.